Found 5 matching trials
Clinical Phase I Study Investigating MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Advanced Solid Tumors or Chronic Lymphocytic Leukemia PHASE1 MSC2490484A is an investigational drug that is being evaluated for the trea...
Show More Location
Institut Jules Bordet
Learn More & Join Trial
Phase Ib/II Study of M3814 With Etoposide and Cisplatin in Small Cell Lung Cancer (SCLC) Extensive Disease (ED) PHASE1 M3814 is an investigational drug under evaluation for treatment of lung can...
Show More Learn More & Join Trial
Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid Tumors PHASE1 This is an open label, single-arm, multicentre dose escalation (Part 1) and...
Show More Location
Macquarie University
Learn More & Join Trial
Phase 1 Trial of MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Combination With Radiotherapy PHASE1 M3814 was an investigational drug that is being evaluated for the treatment...
Show More Learn More & Join Trial
Study of Peposertib in Combination With Capecitabine and RT in Rectal Cancer PHASE1 The main purpose of the study was to define maximum tolerated dose (MTD), r...
Show More Location
University of Colorado Cancer Center
Learn More & Join Trial